Skip to main content

Urticaria News

Related terms: Urticarial disorders

Acupuncture Offers Some Benefit in Chronic Spontaneous Urticaria

TUESDAY, Nov. 14, 2023 – For patients with chronic spontaneous urticaria (CSU), acupuncture produces a greater improvement in the Weekly Urticaria Activity Score (UAS7), although the difference is...

Skin Diseases Pose a Psychosocial Burden

THURSDAY, Nov. 2, 2023 – Skin diseases can cause a psychosocial burden and feelings of stigmatization, according to a study published online Oct. 8 in the Journal of the European Academy of ...

FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications

South San Francisco, CA – April 12, 2021 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the...

FDA Approves Quzyttir (cetirizine) Injection for the Treatment of Acute Urticaria

October 11, 2019 - The U.S. Food and Drug Administration (FDA) has approved Quzyttir (cetirizine hydrochloride) injection for the treatment of acute urticaria in adults and children 6 months of age...

FDA Approves Xolair (omalizumab) for Chronic Idiopathic Urticaria

South San Francisco, Calif. – March 21, 2014 – Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved Xolair (omalizumab) for the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Dermatological Disorders

Related drug support groups

Benadryl, Zyrtec, Claritin, diphenhydramine, Allegra, loratadine, promethazine, cetirizine, famotidine, view more... Xolair, doxepin, Phenergan, fexofenadine, cyproheptadine, omalizumab